Qiagen : Strong Q3 2023 results drive rise in EPS guidance
>Q3 results above our and the consensus estimates - Qiagen reported a strong set of Q3 results. Sales at CER came in at $ 502m, 1% above our ($ 495m), 2% above consensus estimates ($ 492m) and ahead of the company’s guidance of $ 495m. Y-o-y, sales increased by 5.5% despite Qiagen’s solution to gradually exit the NeuMoDx business. The company benefited predominantly from tailwind, driven by continuously strong growth of QuantiFERON (+10% to $ 122m) and QIAstat-DX (+40...
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.